Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Maternal-Fetal Medicine

What Does a CMV IgG Avidity Test Mean in Pregnancy?

At a Glance

A CMV IgG avidity test estimates how recently a pregnant person was infected: low avidity usually suggests a recent infection, while high avidity usually suggests an older one. Results are not perfect and cannot show whether the baby is infected or predict severity.

An IgG avidity test measures how tightly your immune system’s antibodies bind to the cytomegalovirus (CMV). For pregnant women who test positive for CMV antibodies, this test helps doctors estimate roughly when the infection occurred [1]. The timing of the infection is critical because it significantly affects the potential risk to your developing baby.

When your body first fights off a CMV infection, it produces antibodies that bind loosely to the virus. Over the following months, these antibodies mature and learn to bind much more tightly [1]. The “avidity” refers to this binding strength. By measuring it, your doctor can look for clues about whether your infection is new (a primary infection) or if it happened in the past [2].

Why Your Doctor Ordered This Test

If a routine blood test shows that you have CMV antibodies, it generally means you have been exposed to the virus [2].

  • IgG antibodies show that you have had CMV at some point in your life.
  • IgM antibodies are usually the first to appear after a new infection.

However, an IgM test alone cannot reliably tell when the infection happened. IgM antibodies can remain in your blood for many months after an old infection, or they can sometimes appear due to a different virus entirely [3].

Because the risk of the virus causing severe developmental problems for your baby is highest if you catch CMV for the first time just before or during pregnancy, your doctor ordered the IgG avidity test to help clarify the timeline [4][5].

What Your Results Mean

Avidity is usually reported as low, high, or intermediate. The exact timelines depend on the specific laboratory and the test they use. It is important to know that avidity is not a perfect clock, but it provides a helpful estimate:

  • Low Avidity: This means the antibodies are binding loosely, suggesting a recent infection. Depending on the lab’s test, this usually points to an infection within the past 3 to 4 months [6][3]. If you are early in your pregnancy, a low avidity result suggests you may have caught the virus right around conception or during pregnancy. This carries a higher risk of passing the virus to your baby [4].
  • High Avidity: This means your antibodies bind tightly, suggesting the infection occurred further in the past [7]. If you are tested early in your first trimester and have high avidity, it generally means you were infected before you became pregnant, which significantly lowers the risk of severe complications for your baby [5][4]. However, a high avidity test later in pregnancy could mean you were infected earlier in the same pregnancy.
  • Intermediate (Moderate) Avidity: This result is in a gray area and does not provide a clear timeline [8]. Your doctor will need to look at your full medical history, and may repeat the test later or use other methods to understand your situation [5].

Understanding the Risks to Your Baby

The timing of your CMV infection plays a major role in your baby’s health:

  • Transmission risk vs. severity: The chance of passing the virus to your baby actually increases as your pregnancy progresses. In one specific study, transmission rates were roughly 10% for infections around conception, 41% during the first trimester, and 52% during the second trimester [4][9]. However, if the virus does cross the placenta early in pregnancy, the consequences for the baby (such as hearing loss or developmental issues) tend to be much more severe [4][10]. Late-pregnancy infections are more common but usually cause fewer serious problems.

Important context:

  • Avidity only tests the mother: It does not tell you if the virus has actually crossed the placenta or if the baby is infected [11].
  • High avidity does not mean zero risk: While a past infection (high avidity) lowers the risk significantly, the virus can sometimes reactivate, or you could be reinfected with a different strain [12][13].
  • Symptoms are unreliable: Many primary CMV infections cause no symptoms at all. You cannot rely on having had (or not having had) a fever or swollen glands to date your infection.

Next Steps After Your Results

If your avidity test and overall bloodwork suggest a recent primary infection, your care team will likely recommend closer monitoring and discuss your options:

  • Specialist Referrals: You may be referred to a maternal-fetal medicine specialist who has expertise in managing complex pregnancies [14].
  • Targeted Ultrasounds: Your doctor will likely recommend detailed, regular ultrasounds to check the baby’s growth and look for signs of infection. In some cases, if ultrasounds show concerning signs, a specialized fetal MRI might be considered [15][16]. Keep in mind that a normal ultrasound is reassuring but cannot entirely rule out an infection or future complications like hearing loss [10][17].
  • Amniocentesis: This is an invasive procedure that takes a small sample of amniotic fluid to test directly for the virus. It is the most accurate way to find out if the baby has been infected, but it carries a small risk of complications, such as miscarriage. Guidelines often recommend doing this after 21 weeks of pregnancy and at least 6 to 8 weeks after your estimated time of infection [3][10]. Importantly, while amniocentesis can confirm if the baby is infected, it cannot predict how severely the baby will be affected.

Common questions in this guide

Why might I need a CMV IgG avidity test during pregnancy?
If blood tests show CMV antibodies, an avidity test measures how strongly your IgG antibodies bind to CMV. This helps estimate whether the infection is recent or happened in the past, which can help your care team assess possible risks to the developing baby.
What does low CMV IgG avidity mean?
Low avidity usually suggests that a CMV infection happened recently, often within the past three to four months, although the timeframe depends on the laboratory test. If the result is early in pregnancy, your doctor may consider whether the infection occurred around conception or during pregnancy.
What does high CMV IgG avidity mean in early pregnancy?
High avidity usually suggests that the CMV infection occurred further in the past. When it is found early in the first trimester, it generally points to infection before pregnancy and lowers the risk of serious complications for the baby, although it does not make the risk zero.
Can a CMV avidity test tell whether my baby is infected?
No. The avidity test measures the pregnant patient's antibodies and does not show whether CMV has crossed the placenta. Ultrasound monitoring and, when appropriate, amniocentesis may provide additional information about fetal infection, but testing cannot predict the exact severity of future effects.
What does intermediate CMV avidity mean?
Intermediate avidity is an uncertain result that does not establish when the infection occurred. Your doctor may consider your pregnancy timing, other blood results, medical history, repeat testing, or additional evaluation.
What follow-up tests may be discussed after a recent CMV infection?
Your care team may recommend consultation with a maternal-fetal medicine specialist and detailed, repeated ultrasounds. In selected situations, fetal MRI or amniocentesis may be discussed; amniocentesis can test whether the baby is infected but cannot predict how severely the baby will be affected.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Cytomegalovirus Infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What were my exact avidity results, and what timeframe do they point to for my infection based on the specific lab test used?
  2. 2.Based on my complete bloodwork and how far along I am, what is the estimated risk of the virus being transmitted to my baby?
  3. 3.Do you recommend an amniocentesis to check if the baby has been infected, and if so, what are the exact risks of the procedure for my pregnancy?
  4. 4.What would a positive or negative amniocentesis result actually change about our monitoring or treatment plan?
  5. 5.Should I be referred to a maternal-fetal medicine specialist for further evaluation and targeted ultrasounds?

References

References (17)
  1. 1

    The significance of antigen-antibody-binding avidity in clinical diagnosis.

    Li Y, Yang HS, Klasse PJ, Zhao Z

    Critical reviews in clinical laboratory sciences 2025; (62(1)):9-23 doi:10.1080/10408363.2024.2379286.

    PMID: 39041650
  2. 2

    Comparison of two serological screening strategies for cytomegalovirus primary infection in the first trimester of pregnancy.

    Fourgeaud J, Nguyen CÂ, Guilleminot T, et al.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2023; (169()):105614 doi:10.1016/j.jcv.2023.105614.

    PMID: 37982548
  3. 3

    Diagnosis and antenatal management of congenital cytomegalovirus infection.

    , Hughes BL, Gyamfi-Bannerman C

    American journal of obstetrics and gynecology 2016; (214(6)):B5-B11.

    PMID: 26902990
  4. 4

    Evaluation and Management of Congenital Cytomegalovirus Infection.

    Coskun E, Kakkar F, Riley LE, et al.

    Obstetrics and gynecology 2025; (145(3)):297-306 doi:10.1097/AOG.0000000000005840.

    PMID: 39847776
  5. 5

    Comparative performance of CMV IgM and IgG avidity assays for diagnosing a recent primary infection in the first trimester of pregnancy.

    Veyrenche N, Fourgeaud J, Mekouar M, et al.

    Journal of clinical microbiology 2026; (64(9)):e0054526 doi:10.1128/jcm.00545-26.

    PMID: 42573416
  6. 6

    Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.

    Ikuta K, Koshizuka T, Kanno R, et al.

    Microbiology and immunology 2019; (63(5)):172-178 doi:10.1111/1348-0421.12683.

    PMID: 31012489
  7. 7

    Evaluation of the new LIAISON(®) CMV IgG, IgM and IgG Avidity II assays.

    Delforge ML, Desomberg L, Montesinos I

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015; (72()):42-5.

    PMID: 26395519
  8. 8

    Combination of line immunoassays Mikrogen recomLine CMV IgG and recomLine CMV IgG Avidity helps to date the onset of CMV primary infection.

    Delforge ML, Eykmans J, Steensels D, et al.

    Diagnostic microbiology and infectious disease 2019; (93(3)):208-212 doi:10.1016/j.diagmicrobio.2018.09.013.

    PMID: 30361044
  9. 9

    New data on efficacy of valacyclovir in secondary prevention of maternal-fetal transmission of cytomegalovirus.

    Egloff C, Sibiude J, Vauloup-Fellous C, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (61(1)):59-66 doi:10.1002/uog.26039.

    PMID: 35900718
  10. 10

    Cytomegalovirus infection in pregnancy - An update.

    Navti OB, Al-Belushi M, Konje JC,

    European journal of obstetrics, gynecology, and reproductive biology 2021; (258()):216-222 doi:10.1016/j.ejogrb.2020.12.006.

    PMID: 33454510
  11. 11

    Universal Screening With Use of Immunoglobulin G Avidity for Congenital Cytomegalovirus Infection.

    Tanimura K, Tairaku S, Morioka I, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017; (65(10)):1652-1658 doi:10.1093/cid/cix621.

    PMID: 29020153
  12. 12

    Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review.

    Iijima S

    Journal of clinical medicine 2022; (11(17)) doi:10.3390/jcm11175006.

    PMID: 36078936
  13. 13

    Maternal Cytomegalovirus (CMV) Serology: The Diagnostic Limitations of CMV IgM and IgG Avidity in Detecting Congenital CMV Infection.

    Chan ES, Suchet I, Somerset D, et al.

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2024; (27(6)):530-544 doi:10.1177/10935266241253477.

    PMID: 39270128
  14. 14

    Diagnosis and management of congenital Cytomegalovirus: Critical Appraisal of Clinical Practice Guidelines.

    Sorrenti S, Elbarbary N, D'Antonio F, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2025; (306()):172-180 doi:10.1016/j.ejogrb.2025.01.020.

    PMID: 39848071
  15. 15

    First-line noninvasive management of cytomegalovirus primary infection in pregnancy.

    Denef M, Noel L, Bruck G, et al.

    Journal of perinatal medicine 2022; (50(3)):270-276 doi:10.1515/jpm-2021-0384.

    PMID: 34923781
  16. 16

    Role of fetal magnetic resonance imaging in fetuses with congenital cytomegalovirus infection: multicenter study.

    Di Mascio D, Rizzo G, Khalil A, et al.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2023; (61(1)):67-73 doi:10.1002/uog.26054.

    PMID: 36056700
  17. 17

    Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention.

    Naing ZW, Scott GM, Shand A, et al.

    The Australian & New Zealand journal of obstetrics & gynaecology 2016; (56(1)):9-18 doi:10.1111/ajo.12408.

    PMID: 26391432

This page is for informational purposes only and does not constitute medical advice. Your obstetric or maternal-fetal medicine team should interpret your CMV results and discuss testing options for your pregnancy.